NCT00025649 - Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | Biotech Hunter

Timeline

Start Date

July 31, 1999

Study Completion Date

March 31, 2009

Conditions

Neuroblastoma

Interventions

BIOLOGICAL

filgrastim

DRUG

busulfan

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

melphalan

DRUG

vincristine sulfate

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

conventional surgery

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (11)

2100

Rigshospitalet, Copenhagen

16148

Istituto Giannina Gaslini, Genoa

31026

Centre Hospitalier Regional de Purpan, Toulouse

41685

Ostra Sjukhuset, Gothenburg

46009

Hospital Universitario LA FE, Valencia

A-1090

St. Anna Children's Hospital, Vienna

B-9000

Universitair Ziekenhuis Gent, Ghent

0027

Rikshospitalet University Hospital, Oslo

1099-023 Codex

Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A., Lisbon

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

BS2 8BJ

Bristol Royal Hospital for Children, Bristol

All Listed Sponsors

lead

European Infant Neuroblastoma Study Group - 1999

OTHER